Veterans Affairs research under threat

Abstract: In the torrent of hasty and ill-informed actions threatening crucial research across the federal government, headlines have focused on the potentially devastating effects of cutting extramural research funding for the National Institutes of Health (NIH) and National Science Foundation (NSF). Overshadowed by the changes affecting universities and academic medical centers are potentially crippling cuts to the smaller but critically important intramural research program in the Department of Veterans Affairs (VA). Sudden, arbitrary personnel decisions are placing thousands of researchers and tens of millions of dollars of ongoing research at risk and threatening the future of a $2 billion research enterprise that extends back more than 80 years.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P